Medicare Enrolled

Dr. Barbara Chen, MD

Obstetrics & Gynecology · Grapevine, TX
1600 W COLLEGE ST, Grapevine, TX 76051
8174107982
Registered in NPPES since 2007
NPI: 1831309897 verify on NPPES ↗
High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chen from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chen? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chen

Dr. Barbara Chen is an obstetrics & gynecology specialist in Grapevine, TX, with 19 years of NPI registration.

Between the years covered by Open Payments, Dr. Chen received a total of $5,022 from 46 pharmaceutical and/or device companies across 138 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chen is High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration $5,022 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$5,022
Total received (2018-2024)
Avg $717/year across 7 years
Top 14% in TX for obstetrics & gynecology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
138
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,659
2023
$298
2022
$896
2021
$636
2020
$537
2019
$813
2018
$182

Payments by company (2024)

MIMEDX Group, Inc.
$1,418
Organon Llc
$45
Lilly USA, LLC
$39
Molnlycke Health Care US, LLC
$32
PFIZER INC.
$23
MILLICENT US INC
$22
SHIELD THERAPEUTICS INC
$21
Minerva Surgical, Inc
$16
Biogen, Inc.
$15
Novo Nordisk Inc
$14
ABBVIE INC.
$14
Top 3 companies account for 90.5% of 2024 payments
All-time payments by company (2018-2024) ›
MIMEDX Group, Inc.
$1,418
Novo Nordisk Inc
$867
AbbVie Inc.
$305
Novartis Pharmaceuticals Corporation
$219
Biohaven Pharmaceutical Holding Company Ltd.
$181
MILLICENT US INC
$180
Bayer HealthCare Pharmaceuticals Inc.
$178
ABBVIE INC.
$166
Genentech USA, Inc.
$132
Exeltis, USA Inc.
$124
AbbVie, Inc.
$108
MAYNE PHARMA COMMERCIAL LLC
$105
Janssen Biotech, Inc.
$104
MAYNE PHARMA INC.
$91
Pharmacyclics LLC, An AbbVie Company
$82
TherapeuticsMD, Inc.
$63
AMAG Pharmaceuticals, Inc.
$56
PFIZER INC.
$47
Organon Llc
$45
Duchesnay USA Incorporated
$39
Lilly USA, LLC
$39
Myovant Sciences Inc.
$37
Molnlycke Health Care US, LLC
$32
Channel Medsystems, Inc.
$32
Bayer Healthcare Pharmaceuticals Inc.
$28
Minerva Surgical, Inc
$27
Pacira Pharmaceuticals Incorporated
$21
SHIELD THERAPEUTICS INC
$21
Seagen Inc.
$21
Rhythm Pharmaceuticals, Inc.
$18
Gilead Sciences, Inc.
$18
Vertical Pharmaceuticals, LLC
$18
Evofem Biosciences, Inc.
$17
Smith+Nephew, Inc.
$16
Merck Sharp & Dohme Corporation
$16
Takeda Pharmaceuticals U.S.A., Inc.
$16
Biogen, Inc.
$15
Karyopharm Therapeutics Inc.
$15
VIVUS LLC
$15
Organon LLC
$14
Baxter Healthcare
$13
Astellas Pharma US Inc
$13
DySIS Medical, Inc.
$13
Meditrina
$13
Allergan, Inc.
$12
Allergan Inc.
$11
Top 3 companies account for 51.6% of all-time payments
Associated products mentioned in payments ›
ABRYSVO · ACCRUFER · ANNOVERA · Amitiza · COMIRNATY · DARZALEX · DIVIGEL · Endometrial Ablation System (Device) · Exparel · FEMRING · Femring · IMVEXXY · INTRAROSA · Imbruvica · JADA SYSTEM · KISQALI · Kyleena · LILETTA · LO LOESTRIN FE · MAKENA · MYFEMBREE · Mepilex Border Post-Op Ag · Mirena · NEXPLANON · NURTEC ODT · ORIAHNN · ORILISSA · Orilissa · Osphena · PADCEV · PICO7 · Perjeta · Phexxi · Qsymia · SLYND · Saxenda · Slynd · Stivarga · TASIGNA · TECENTRIQ · TISSEEL · Trodelvy · Ultra 2.0 · Veozah · Vitafol Ultra · Wegovy · XPOVIO · ZEPBOUND · ZURZUVAE
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an obstetrics & gynecology specialist in Grapevine?
Compare obstetricians & gynecologists in the Grapevine area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists in nearby ZIP areas
761
County median income
$81,905
Nearest hospital to ZIP centroid (approximate)
BAYLOR SCOTT & WHITE MEDICAL CENTER GRAPEVINE
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data — No data N/A
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chen is an obstetrics & gynecology specialist, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Chen receive payments from pharmaceutical companies?
Yes. Dr. Chen received a total of $5,022 from 46 companies across 138 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently High for Dr. Chen) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →